Xi Long

机构：Chongqing Academy of Animal Science · ORCID：0009-0000-5901-3218

发表论文 52 篇 · 总被引 1220 次 · h-index 15

代表论文

• AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor (2023 · Chemical Science · 被引 341)
• PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery (2024 · Journal of Chemical Information and Modeling · 被引 137)
• Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform (2022 · Frontiers in Aging Neuroscience · 被引 101)
• Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine (2022 · Aging · 被引 84)
• A comprehensive AI ‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and aging (2023 · Aging Cell · 被引 42)
• LINC00205 modulates the expression of EPHX1 through the inhibition of miR‐184 in hepatocellular carcinoma as a ceRNA (2019 · Journal of Cellular Physiology · 被引 39)